Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$17.53 - $22.98 $1.75 Million - $2.3 Million
100,000 New
100,000 $2.06 Million
Q3 2022

Nov 14, 2022

BUY
$12.01 - $19.45 $464,666 - $752,520
38,690 Added 8.39%
500,000 $6.83 Million
Q2 2022

Aug 03, 2022

BUY
$10.71 - $18.33 $1.33 Million - $2.28 Million
124,310 Added 36.89%
461,310 $8.46 Million
Q1 2022

May 12, 2022

BUY
$11.78 - $16.98 $2.97 Million - $4.28 Million
252,000 Added 296.47%
337,000 $5.42 Million
Q4 2021

Feb 02, 2022

BUY
$12.22 - $19.57 $305,500 - $489,250
25,000 Added 41.67%
85,000 $1.19 Million
Q3 2021

Nov 12, 2021

SELL
$15.42 - $21.72 $154,200 - $217,200
-10,000 Reduced 14.29%
60,000 $1.12 Million
Q2 2021

Aug 30, 2021

SELL
$20.85 - $29.88 $1.46 Million - $2.09 Million
-70,000 Reduced 50.0%
70,000 $1.46 Million
Q2 2021

Aug 13, 2021

BUY
$20.85 - $29.88 $1.67 Million - $2.39 Million
80,000 Added 133.33%
140,000 $2.92 Million
Q1 2021

May 10, 2021

SELL
$24.75 - $39.14 $866,250 - $1.37 Million
-35,000 Reduced 36.84%
60,000 $1.7 Million
Q4 2020

Feb 16, 2021

BUY
$29.0 - $41.62 $1.31 Million - $1.87 Million
45,000 Added 90.0%
95,000 $3.1 Million
Q3 2020

Nov 16, 2020

BUY
$16.3 - $30.64 $815,000 - $1.53 Million
50,000 New
50,000 $1.53 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $603M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.